Can a nerve protector slow glaucoma damage?
NCT ID NCT06437639
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This study tested a medicine called Mexidol in 80 adults with advanced primary open-angle glaucoma. The goal was to see if it can protect the eye's nerve cells and help control the disease. Researchers measured changes in cell energy and vision over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA (POAG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tyumen Scientific Center of the Russian Academy of Sciences
Tyumen, Russian Federation, 625026, Russia
Conditions
Explore the condition pages connected to this study.